Physician's awareness of the prevention of corticosteroid induced osteoporosis.
| dc.contributor.author | Ungprasert, Supparat | en_US |
| dc.contributor.author | Wangkaew, Suparaporn | en_US |
| dc.contributor.author | Louthrenoo, Worawit | en_US |
| dc.date.accessioned | 2009-05-27T20:19:26Z | |
| dc.date.available | 2009-05-27T20:19:26Z | |
| dc.date.issued | 2007-01-12 | en_US |
| dc.description | Chotmaihet Thangphaet. | en_US |
| dc.description.abstract | BACKGROUND AND OBJECTIVE: Corticosteroid induced osteoporosis (CIO) is a preventable condition that is often not realized by physicians who prescribe corticosteroids. The present study was carried out to study the awareness of CIO prevention in a teaching hospital. MATERIAL AND METHOD: The medical records of patients who received corticosteroids equivalent to prednisolone of > or = 5 mg/day for a minimum of 3 months between 1 May 2004 and 30 June 2004 were reviewed. RESULTS: Four hundred and forty nine patients of 1,540 who received corticosteroids (29.1%) were included in the present study. Rheumatologists, nephrologists, and dermatologists were the top three specialists to prescribe corticosteroids in 189 (42.1%), 103 (23.0%), and 46 (10.2%) cases, respectively. Only 146 patients (32.5%) received calcium supplement. Rheumatologists and neurologists were the top two specialists to prescribe calcium supplementation in 100 of 189 (52.9%) and 13 of 36 (36.1%) cases, respectively. Bone mineral density measurement was determined in only 26 of the 449 patients (5.8%). CONCLUSION: Prevention of CIO is still neglected by internal medicine specialists, even in a teaching hospital. An educational campaign for physicians is warranted to improve the practice for the prevention of this treatable complication. | en_US |
| dc.description.affiliation | Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. | en_US |
| dc.identifier.citation | Ungprasert S, Wangkaew S, Louthrenoo W. Physician's awareness of the prevention of corticosteroid induced osteoporosis. Journal of the Medical Association of Thailand. 2007 Jan; 90(1): 59-64 | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/42786 | |
| dc.language.iso | eng | en_US |
| dc.source.uri | https://www.mat.or.th/journal/all.php | en_US |
| dc.subject.mesh | Adolescent | en_US |
| dc.subject.mesh | Adult | en_US |
| dc.subject.mesh | Aged | en_US |
| dc.subject.mesh | Aged, 80 and over | en_US |
| dc.subject.mesh | Calcium --therapeutic use | en_US |
| dc.subject.mesh | Clinical Competence | en_US |
| dc.subject.mesh | Glucocorticoids --administration & dosage | en_US |
| dc.subject.mesh | Humans | en_US |
| dc.subject.mesh | Middle Aged | en_US |
| dc.subject.mesh | Osteoporosis --chemically induced | en_US |
| dc.subject.mesh | Prednisolone --administration & dosage | en_US |
| dc.title | Physician's awareness of the prevention of corticosteroid induced osteoporosis. | en_US |
| dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1